Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study
XAV-19(一种猪源糖基人源化多克隆抗SARS-CoV-2抗体)治疗COVID-19相关中度肺炎的药代动力学和安全性:一项随机、双盲、安慰剂对照的IIa期研究
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.01237-21
Gaborit, Benjamin; Dailly, Eric; Vanhove, Bernard; Josien, Régis; Lacombe, Karine; Dubee, Vincent; Ferre, Virginie; Brouard, Sophie; Ader, Florence; Vibet, Marie-Anne; Le Thuaut, Aurélie; Danger, Richard; Flet, Laurent; Omnes, Anne; Berly, Laetitia; Chiffoleau, Anne; Jobert, Alexandra; Duvaux, Odile; Raffi, François